Cargando…
Impact of COVID-19 on management of clinical trials and the potential mitigating strategies
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267996/ https://www.ncbi.nlm.nih.gov/pubmed/37325576 http://dx.doi.org/10.4103/picr.picr_25_22 |
_version_ | 1785059045272453120 |
---|---|
author | Sarve, Parag Gawali, Vijaykumar Ali, Heena Tattu, Sarvajnya Chetule, Charulata |
author_facet | Sarve, Parag Gawali, Vijaykumar Ali, Heena Tattu, Sarvajnya Chetule, Charulata |
author_sort | Sarve, Parag |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10267996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-102679962023-06-15 Impact of COVID-19 on management of clinical trials and the potential mitigating strategies Sarve, Parag Gawali, Vijaykumar Ali, Heena Tattu, Sarvajnya Chetule, Charulata Perspect Clin Res Brief Communication Wolters Kluwer - Medknow 2023 2022-07-27 /pmc/articles/PMC10267996/ /pubmed/37325576 http://dx.doi.org/10.4103/picr.picr_25_22 Text en Copyright: © 2022 Perspectives in Clinical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Brief Communication Sarve, Parag Gawali, Vijaykumar Ali, Heena Tattu, Sarvajnya Chetule, Charulata Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title | Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title_full | Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title_fullStr | Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title_full_unstemmed | Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title_short | Impact of COVID-19 on management of clinical trials and the potential mitigating strategies |
title_sort | impact of covid-19 on management of clinical trials and the potential mitigating strategies |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267996/ https://www.ncbi.nlm.nih.gov/pubmed/37325576 http://dx.doi.org/10.4103/picr.picr_25_22 |
work_keys_str_mv | AT sarveparag impactofcovid19onmanagementofclinicaltrialsandthepotentialmitigatingstrategies AT gawalivijaykumar impactofcovid19onmanagementofclinicaltrialsandthepotentialmitigatingstrategies AT aliheena impactofcovid19onmanagementofclinicaltrialsandthepotentialmitigatingstrategies AT tattusarvajnya impactofcovid19onmanagementofclinicaltrialsandthepotentialmitigatingstrategies AT chetulecharulata impactofcovid19onmanagementofclinicaltrialsandthepotentialmitigatingstrategies |